A Comparative Analysis of Transarterial Downstaging for Hepatocellular Carcinoma: Chemoembolization Versus Radioembolization
Robert J. Lewandowski(Society of Interventional Radiology), Riad Salem(Northwestern University), Mary F. Mulcahy(Northwestern University), Reed A. Omary(Vanderbilt University), Sean Senthilnathan(Toronto General Hospital), Robert K. Ryu(University of Colorado Anschutz Medical Campus), Michaël Abécassis(University of Arizona), Ahsun Riaz(Northwestern University), Frank H. Miller(Northwestern University), Laura Kulik(Northwestern University), Talia Baker(University of Utah), S.M. Ibrahim(Northwestern Memorial Hospital), K.T. Sato(Johns Hopkins University)
Cited by 581
Related Papers
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
|Hepatology|2018|4.7k
AASLD guidelines for the treatment of hepatocellular carcinoma
|Hepatology|2017|4.2k
Hepatobiliary Cancers
|Journal of the National Comprehensive Cancer Network|2009|2.3k
Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study
|The Lancet|2020|1.8k
The International Position on Laparoscopic Liver Surgery
|Annals of Surgery|2009|1.5k